Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.

Canavan describes how flexible working positively impacts his team.

For patients with lung cancer, biomarker testing may be an option.

Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.